Barclays PLC PROGENICS PHARMACEUTICALS IN Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
N/A
-73,821 Closed
0 $0
Q1 2020

May 13, 2020
SELL
N/A
-343,593 Reduced 82.31%
73,821 $280,000
Q4 2019

Feb 10, 2020
BUY
N/A
220,865 Added 112.37%
417,414 $2.12 Million
Q3 2019

Nov 14, 2019
SELL
N/A
-32,552 Reduced 14.21%
196,549 $993,000
Q2 2019

Aug 14, 2019
BUY
N/A
99,173 Added 76.33%
229,101 $1.41 Million
Q1 2019

May 15, 2019
BUY
N/A
67,436 Added 107.91%
129,928 $603,000
Q4 2018

Feb 14, 2019
SELL
N/A
-121,843 Reduced 66.1%
62,492 $262,000
Q3 2018

Nov 14, 2018
SELL
N/A
-10,171 Reduced 5.23%
184,335 $1.16 Million
Q2 2018

Aug 14, 2018
BUY
N/A
101,242 Added 108.55%
194,506 $1.56 Million
Q1 2018

May 15, 2018
BUY
N/A
20,578 Added 28.31%
93,264 $696,000
Q4 2017

Feb 14, 2018
SELL
N/A
-13,814 Reduced 15.97%
72,686 $433,000
Q3 2017

Nov 14, 2017
BUY
N/A
86,500
86,500 $637,000
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email